What is the treatment for acute dystonic reaction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The treatment for acute dystonic reaction should primarily involve anticholinergic medications, with the goal of rapidly relieving symptoms and preventing recurrence, as recommended by the American Psychiatric Association 1. The most effective treatment approach for acute dystonic reaction involves administering anticholinergic medications, such as benztropine (Cogentin) or diphenhydramine (Benadryl), to rapidly relieve symptoms.

  • For adults, benztropine 1-2 mg can be administered intramuscularly or intravenously, while diphenhydramine 25-50 mg can be given intravenously or intramuscularly.
  • For children, diphenhydramine 1 mg/kg up to 50 mg is preferred. After the acute episode resolves, oral anticholinergic medication should be continued for 2-3 days to prevent recurrence, such as benztropine 1-2 mg twice daily or diphenhydramine 25-50 mg three to four times daily 1. It is essential to discontinue or reduce the dose of the offending agent, typically antipsychotics, antiemetics, or other dopamine-blocking drugs, if possible. Patients should be monitored for anticholinergic side effects, including dry mouth, blurred vision, urinary retention, and confusion, which are usually mild and transient 1. The American Psychiatric Association recommends treating patients who have acute dystonia associated with antipsychotic therapy with an anticholinergic medication 1. This approach prioritizes reducing morbidity, mortality, and improving quality of life for patients experiencing acute dystonic reactions.

From the FDA Drug Label

In acute dystonic reactions, 1 to 2 mL of the injection usually relieves the condition quickly. The treatment for acute dystonic reaction is 1 to 2 mL of benztropine mesylate injection which usually provides quick relief 2.

  • The dose can be repeated if the condition returns.
  • The recommended dosage is 1 to 4 mg once or twice a day parenterally.
  • Dosage must be individualized according to the need of the patient.

From the Research

Treatment Options for Acute Dystonic Reaction

The treatment for acute dystonic reaction typically involves the use of anticholinergic or antidopaminergic medications.

  • Anticholinergic drugs, such as benztropine mesylate 3 or biperiden 4, have been shown to be effective in treating acute dystonic reactions.
  • Diphenhydramine, an antihistamine with anticholinergic properties, can also be used to treat acute dystonic reactions, although it has been reported to cause dystonic reactions in some cases 5.
  • In some cases, benzodiazepines, such as diazepam, may be used to treat acute dystonic reactions 5.

Medication Administration

These medications can be administered intramuscularly or intravenously, depending on the severity of the reaction and the patient's condition.

  • Benztropine mesylate has been shown to be effective in reducing recovery time in patients with acute dystonic reactions 3.
  • Biperiden has been used to treat acute dystonic reactions, particularly those induced by metoclopramide 4.

Important Considerations

It is essential to monitor patients for extrapyramidal side effects, such as dystonic reactions, when administering medications that can cause these symptoms, such as metoclopramide 4.

  • Patients who are prone to dystonic reactions, such as those with a history of drug abuse or those taking high doses of metoclopramide, should be closely monitored for signs of acute dystonic reaction 3, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Metoclopramide induced acute dystonic reaction: A case report.

Annals of medicine and surgery (2012), 2022

Research

Diphenhydramine induced acute dystonia: a case report.

The Pan African medical journal, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.